My physician labels me Ozempic's poster child - here's the common mistake many make

Early Struggles and Health Challenges

During a tough period in Aisling McCarthy's life, she endured severe discomfort and avoided her reflection.

Diagnosed with arthritis and fibromyalgia in her early thirties, the mother of one grappled with intense pain radiating through her back, hips, and hands, leading to depression.

'I felt utterly drained, as if my entire body was engulfed in flames,' the 43-year-old shared with Metro. 'To cope, I turned to food for comfort, indulging constantly in toffee popcorn, chocolate bars, muffins, and ice cream. This led to reduced mobility and further weight accumulation.'

While expecting her daughter in 2014, Aisling frequently relied on crutches or a wheelchair, and after Bethany, now 10, arrived, the new mother lacked the strength to pick her up.

Attempting Weight Loss and Discovering Ozempic

At 17 and a half stone, Aisling aimed to improve her health while embracing her figure, experimenting with various diets like Slimming World and Slimfast shakes. Though she saw initial progress, it proved temporary. 'I'd regain the weight due to hunger,' she recalled.

During a GP visit in early 2022, Ozempic came up. The semaglutide medication had recently received EMA approval for weight management in November 2021, initially for diabetes.

'Few discussed Ozempic for weight loss then, so I worried about injecting an unfamiliar substance. Awareness wasn't widespread like today,' she noted.

To alleviate fears, Aisling reached out to manufacturer Novo Nordisk for details. She discovered it replicates GLP-1 hormone, controlling hunger and digestion to promote fullness with smaller portions. 'Despite nerves, I trusted it might succeed, so I proceeded,' she added.

Starting the Treatment and Initial Hurdles

Upon prescription, Aisling administered 0.25mg weekly injections, increasing to double after four weeks and 1mg two months later.

The beginning proved challenging; nausea and tiredness persisted for six weeks. 'My doctor inquired if I was eating,' she said. 'Ozempic silenced food cravings so effectively that I ate just one meal daily. I set alarms every two hours to prompt eating.'

Weight loss began immediately, though visible changes took three months, despite looser clothing.

Additionally, Aisling gained vitality and assurance, enhancing her relationship with husband Jonathan. 'He supported me wholeheartedly,' she grinned.

Social Reactions and Personal Transformation

Friends in Cork observed the shifts, with responses like 'you lucky thing' as she openly shared her method.

Crucially, her self-perception transformed: 'I shifted from self-hatred to self-love, a tough journey. Reduced pain allows activities I missed since my twenties.'

A 2023 France trip highlighted progress when Jonathan's expired passport forced Aisling to travel solo with Bethany, something impossible before. 'Sliding down with her on holiday felt monumental; previously, I couldn't climb the steps.'

Ending Treatment and Maintaining Gains

After a year, Aisling hit her target of 11st and ceased Ozempic due to satisfaction with her shape and supply shortages from demand. 'Delays turned unavailable; I feared mental strain if forced off,' she explained.

Subsequently, she underwent breast reduction and apronectomy for excess skin, now at 10st and 9lbs. 'No more talcum powder to prevent issues,' she remarked.

Bucking Trends and Advice for Success

Today, her doctor dubs her Ozempic's 'ideal example,' defying University of Oxford research showing typical regain within a year post-stopping.

'Gradual tapering helped; avoid abrupt cessation to manage returning hunger,' she advised. This enabled smaller portions and limited sweets. Having counseling during use, she stressed mental effort.

'Many seek shortcuts, not tools, ignoring root causes. Stopping revives issues without coping strategies. Address mind and body to prevent mutual undermining.'

UK Rollout and Public Views

Though about 1.5 million in the UK use weight loss injections, June saw GPs approve Mounjaro (tirzepatide) and Wegovy (semaglutide).

The NHS initiative aims to provide jabs to 220,000 needing them most over three years. Health Secretary Wes Streeting notes benefits beyond weight, including reduced NHS dependency.

'It cuts costs,' Aisling agreed, with fewer arthritis and fibromyalgia flares requiring less medication, physio, or dietitian support.

On perceptions: 'Bias and fat shaming persist, often from personal trainers or lifelong thin individuals lacking understanding.'

Social media comments like 'You're still overweight despite loss' bother her. 'I prefer curves; skinniness doesn't fit.'

Risks and Final Thoughts

Aisling acknowledged risks and no side effects herself, cautioning Ozempic isn't for casual weight loss.

'Not a primary option,' she urged. 'Research thoroughly, but pursue health without guilt.'

'Ozempic truly transformed my life; no regrets.'

Health tracking apps like Shotlee can help monitor ongoing health improvements.